Product NDC: | 0173-0739 |
Proprietary Name: | IMITREX |
Non Proprietary Name: | sumatriptan succinate |
Active Ingredient(s): | 4 mg/.5mL & nbsp; sumatriptan succinate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0739 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020080 |
Marketing Category: | NDA |
Start Marketing Date: | 20060406 |
Package NDC: | 0173-0739-00 |
Package Description: | 2 SYRINGE in 1 PACKAGE (0173-0739-00) > .5 mL in 1 SYRINGE |
NDC Code | 0173-0739-00 |
Proprietary Name | IMITREX |
Package Description | 2 SYRINGE in 1 PACKAGE (0173-0739-00) > .5 mL in 1 SYRINGE |
Product NDC | 0173-0739 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sumatriptan succinate |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20060406 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | SUMATRIPTAN SUCCINATE |
Strength Number | 4 |
Strength Unit | mg/.5mL |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |